Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment

被引：0
|
作者：
Liu Yang
Wenfei Li
Zhihao Lu
Ming Lu
Jun Zhou
Zhi Peng
Xiaotian Zhang
Xicheng Wang
Lin Shen
Jian Li
机构：
[1] Peking University Cancer Hospital & Institute,Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[2] People’s Hospital of Zhongmu,Department of oncology
来源：
BMC Cancer | / 22卷
关键词：
HER2 positive; Colorectal cancer; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
    Yang, Liu
    Li, Wenfei
    Lu, Zhihao
    Lu, Ming
    Zhou, Jun
    Peng, Zhi
    Zhang, Xiaotian
    Wang, Xicheng
    Shen, Lin
    Li, Jian
    BMC CANCER, 2022, 22 (01)
  • [2] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
  • [3] Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients
    Arslan, U. Y.
    Turker, I.
    Aksoy, S.
    Oksuzoglu, B.
    Helvaci, K.
    Ozdemir, N. Yildirim
    Uyeturk, U.
    Sonmez, O. Uysal
    Budakoglu, B.
    Zengin, N.
    JOURNAL OF BUON, 2013, 18 (03): : 585 - 593
  • [4] Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
    Van Raemdonck, Elisa
    Floris, G.
    Berteloot, P.
    Laenen, A.
    Vergote, I.
    Wildiers, H.
    Punie, K.
    Neven, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 183 - 194
  • [5] HER2 Expression in Circulating Tumor Cells as Prognostic and Predictive Biomarkers for Anti-HER2 Therapy in Previously Treated Metastatic Colorectal Cancer
    Wang, Mengting
    Xu, Ting
    Shen, Lin
    Li, Jian
    Zhu, Ling
    Wang, Chen
    Hu, Zhiyuan
    Li, Ping
    Yang, Yanlian
    Wang, Xicheng
    ADVANCED THERAPEUTICS, 2023, 6 (10)
  • [6] Margetuximab Anti-HER2 monoclonal antibody Treatment of metastatic HER2-positive breast cancer Treatment of HER2-positive gastric or gastroeso-phageal junction cancer
    Hanna, K. S.
    DRUGS OF THE FUTURE, 2021, 46 (03) : 191 - 195
  • [7] Decreased HER2 expression in endometrial cancer following anti-HER2 therapy
    Chui, M. Herman
    Brown, David N.
    Paula, Arnaud Da Cruz
    da Silva, Edaise M.
    Momeni-Boroujeni, Amir
    Reis-Filho, Jorge S.
    Zhang, Yanming
    Makker, Vicky
    Ellenson, Lora Hedrick
    Weigelt, Britta
    JOURNAL OF PATHOLOGY, 2024, 262 (02) : 129 - 136
  • [8] HER2-Positive Metastatic Colorectal Cancer
    Robinson, Hannah R.
    Messersmith, Wells A.
    Lentz, Robert W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (05) : 585 - 604
  • [9] HER2-Positive Metastatic Colorectal Cancer
    Hannah R. Robinson
    Wells A. Messersmith
    Robert W. Lentz
    Current Treatment Options in Oncology, 2024, 25 : 585 - 604
  • [10] HER2 in metastatic colorectal cancer: a new to target to remember
    Bitar, Lynn
    Zouein, Joseph
    Haddad, Fady Gh
    Eid, Roland
    Kourie, Hampig R.
    BIOMARKERS IN MEDICINE, 2021, 15 (02) : 133 - 136
12345